Detalles de la búsqueda
1.
Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT.
Blood
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657278
2.
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.
Ann Hematol
; 103(3): 981-992, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38092996
3.
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654658
4.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 129(23): 3735-3745, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658621
5.
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Br J Haematol
; 201(6): 1169-1178, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949658
6.
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT.
Cancer
; 128(22): 3959-3968, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36110063
7.
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age.
Am J Hematol
; 97(8): 1065-1074, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35696192
8.
Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients.
Br J Haematol
; 186(2): 300-310, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968396
9.
Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia.
Genes Chromosomes Cancer
; 52(7): 619-35, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23580398
10.
MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia.
Clin Epigenetics
; 16(1): 17, 2024 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254139
11.
Haploidentical transplantation in primary refractory/relapsed secondary versus de novo AML: from the ALWP/EBMT.
Blood Adv
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598754
12.
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: A study from the ALWP of the EBMT.
Blood Adv
; 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429091
13.
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
Front Immunol
; 15: 1350470, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38629074
14.
A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk
; 23(5): e232-e239, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863897
15.
Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy.
Leuk Res
; 130: 107314, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37216792
16.
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT.
J Hematol Oncol
; 16(1): 10, 2023 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36782226
17.
Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant
; 58(5): 552-557, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36823454
18.
Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome.
Pathol Oncol Res
; 29: 1610914, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151356
19.
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party.
Bone Marrow Transplant
; 58(1): 54-60, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36216975
20.
Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT.
Hemasphere
; 7(7): e920, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37388926